PharmaBoardroom

Canada’s COVID-19 Vaccination Strategy

Fasken Canada's Dara Jospe and Denis Douville examine Canada's COVID-19 vaccine strategy, from the steps the country has taken to expedite the…

10 Key Insights from PharmaBoardroom Contributors in 2020

Although the COVID-19 pandemic and the subsequent rush to develop diagnostics, therapeutics, and vaccines dominated the global headlines in 2020,…

Top 10 PharmaBoardroom Interviews of 2020

2020 was a challenging year globally, but one in which the importance of the healthcare and life sciences sector was underlined like never before.…

PharmaBoardroom Most Read Interviews of 2020

The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the past year. From Mexico to Morocco…

Italy: Menarini CEO on Averting Future Health Crises; Alfasigma…

A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with Menarini CEO Elcin Barker Ergun, a…

Thomas D. Szucs, European Center of Pharmaceutical Medicine at…

Genomic medicine expert Professor Thomas D. Szucs explains what ignited his interest in the field and how payers and authorities are adapting to the…

Medigen’s Charles Chen on Cell Culture Vaccine Strategies

Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s COVID-19 vaccine strategy, and what…

US Pharma Innovation Factsheet 2020

In a recent article for PharmaBoardroom, Objective Capital's David Crean took a look at the state of US innovation today and its long term…

The Value Proposition of Generics & Biosimilars in the USA

AAM President Dan Leonard highlights the findings of the association’s most recent report and re-states the value proposition of generic and…

Kirsti Nyhus – Market Access & External Affairs…

AbbVie Norway’s Kirsti Nyhus discusses access challenges in the Norwegian market for innovative drugs, the importance of bringing clinical trials…

Jürg Utzinger – Director, Swiss Tropical & Public…

Prof Dr Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) outlines the organisation’s important role within the global…

Why Europe Needs a Sustainable Pharma Manufacturing System

On 25 November, the European Commission adopted a new strategy meant to, among others, allow Europe to cover its pharmaceutical needs, including in…

Tagged with